IN DEPTH

CAR-Ts in China: the dawn of an immunotherapy superpower

Drawing on data to make oncology trials diverse

Covid-19

How delays derailed Covid-19 vaccination in Africa

As we inch closer to WHO’s deadline for vaccinating most of the world’s population, assessing the progress in many African countries requires nuance, writes Andrew Hillman.

R&D

Is pharma doing enough to tackle the opioid epidemic?

Cell Therapy 

Decoding the Covid-19 connection with diabetes

CAR-Ts in China: the dawn of an immunotherapy superpower

Drawing on data to make oncology trials diverse

02/24/2024 07:02:45
  • Home | How delays derailed Covid-19 vaccination in Africa
  • In this issue
  • Contents
  • CSafe Global
  • Briefing
  • Industry news
  • The pharma industry briefing
  • SHL Medical
  • Stormy Studio
  • Comment
  • It will take years for AI use to peak in drug discovery and development process
  • Bear market hits Europe’s innovator drug venture financing, losing pace with US
  • Longevity technology and its future
  • Potential impact on women’s healthcare post-Roe versus Wade
  • Dupixent approval brings first biologic to youngest atopic dermatitis patients
  • BioLife Solutions
  • Mimotopes Company Insight
  • Mimotopes
  • In Depth
  • How delays derailed Covid-19 vaccination in Africa
  • Is pharma doing enough to tackle the opioid epidemic?
  • Decoding the Covid-19 connection with diabetes
  • CAR-Ts in China: the dawn of an immunotherapy superpower
  • Drawing on data to make oncology trials diverse
  • Nipro
  • BEA Technologies
  • In Data
  • The pharmaceutical industry found it harder to fill cybersecurity vacancies in Q1 2022
  • Debt offerings decreased significantly in the pharmaceutical industry in H2 2021
  • Partnerships decreased in the pharmaceutical industry in H2 2021
  • Europe is seeing a hiring boom in pharmaceutical industry big data roles
  • Events
  • Next issue
06/24/2022 00:00:00